CNTX compared with PALI: revenue, margins and what each company keeps, and the suppliers and customers both name

CNTXContext Therapeutics Inc.

Mkt capRevenueRevenue

PALIPalisade Bio, Inc.

Mkt capRevenueRevenue

Compare

CNTXContext Therapeutics Inc.

PALIPalisade Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CNTX 6

—BioAtla, Inc. ("BioAtla")unlistedsupplier

—Integral Molecular, Inc. ("Integral")unlistedsupplier

—Just-Evotec Biologicsunlistedsupplier

—Link (assignment for the benefit of creditors), LLC ("Link")unlistedsupplier

2 more · CNTX chain ›

Shared 0

No shared counterparties.

Only PALI 2

—Giiant Pharmaunlistedsupplier

—Newsoaraunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

CNTXContext Therapeutics Inc.

0.20▲+6.08%· post 0.20· delayed

Mkt cap$17.4MRevenue—

PALIPalisade Bio, Inc.

1.11▼−4.56%· post 1.11· delayed

After hoursNov 2 '26delayed

Mkt cap$202.2MRevenue$500,000Q2 FY26

Compare

After hoursNov 2 '26delayed

CNTXContext Therapeutics Inc.

PALIPalisade Bio, Inc.

0.20▲+6.08%post 0.20delayed

Price

1.11▼−4.56%post 1.11delayed

$17.4M

Mkt cap

$202.2M

—

Revenue

$500,000Q2 FY26

CNTX0.20▲+6.08%vsPALI1.11▼−4.56%After hoursNov 2 '26delayed